• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

The global atrial fibrillation treatment market grew at a CAGR of around 14% during 2014-2019. Atrial fibrillation (AFib) refers to a cardiac condition with irregular and rapid heart rate that increases the risks of stroke, heart failure and other heart-related complications. In this condition, the upper (atrial) chambers beat irregularly and out of coordination with the lower (ventricle) chambers of the heart, thereby causing heart palpitations, shortness of breath and fatigue. It can also lead to the development of blood clots that may disrupt the blood flow to other organs. The main types of AFib include paroxysmal, persistent, long-term persistent, and permanent AFib that can be treated with medications and other interventions to adjust the heart’s electrical impulses. 

The rising prevalence of cardiovascular diseases (CVDs) is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs). This, along with the steadily increasing geriatric population across the globe, is providing a boost to the market growth. Furthermore, the increasing preference for minimally invasive (MI) surgical procedures is also creating a positive impact on the demand for miniaturized surgical devices, implant surgeries and remote nursing. Additionally, various technological advancements, such as the development of catheter ablation devices to remove damaged heart tissues and innovative mapping and recording systems, is acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further. Looking forward, IMARC Group expects the market to continue its strong growth during the next five years.

Breakup by Disorder Type:

  • Paroxysmal Atrial Fibrillation
  • Persistent Atrial Fibrillation
  • Permanent Atrial Fibrillation
  • Others
     

Breakup by Treatment Type:

  • Medical Procedures
    • Surgical Procedures
      • Maze Surgery
      • Catheter Ablation
    • Non-Surgical Procedures
      • Electric Cardioversion
      • Diagnostic Catheters 
      • Mapping and Recording Systems
      • Cardiac Monitors
      • Access Devices
      • Left Atrial Appendage and Closure Devices
      • Intracardiac Echocardiography (ICE) Systems
  • Medication
    • Anticoagulants
    • Anti-Arrhythmics
       

Breakup by End-User:

  • Hospitals
  • Cardiac Labs
  • Ambulatory Surgical Centers
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Atricure Inc., Biotronik, Boston Scientific Corporation, Cardiofocus Inc., Hansen Medical Inc. (Auris Health), Johnson & Johnson, Siemens Healthineers (Cerner Corporation), Stereotaxis Inc., etc.

Key Questions Answered in This Report:

  • How has the global atrial fibrillation treatment market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the disorder type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global atrial fibrillation market treatment and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Atrial Fibrillation Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Market Forecast
6    Market Breakup by Disorder Type
    6.1    Paroxysmal Atrial Fibrillation
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Persistent Atrial Fibrillation
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Permanent Atrial Fibrillation
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Treatment Type
    7.1    Medical Procedures
        7.1.1 Market Trends
        7.1.2 Surgical Procedures
            7.1.2.1 Maze Surgery
            7.1.2.2 Catheter Ablation
        7.1.3 Non-Surgical Devices
            7.1.3.1 Electric Cardioversion
            7.1.3.2 Diagnostic Catheters 
            7.1.3.3 Mapping and Recording Systems
            7.1.3.4 Cardiac Monitors
            7.1.3.5 Access Devices
            7.1.3.6 Left Atrial Appendage and Closure Devices
            7.1.3.7 Intracardiac Echocardiography (ICE) Systems
        7.1.4 Market Forecast
    7.2    Medications
        7.2.1 Market Trends
        7.2.2 Drug Classes
            7.2.2.1 Anticoagulants
            7.2.2.2 Anti-Arrhythmics    
        7.2.3 Market Forecast
8    Market Breakup by End-User
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Cardiac Labs
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Ambulatory Surgical Centers
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Competitive Landscape
    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Abbott Laboratories
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio 
           13.3.1.3 Financials 
           13.3.1.4 SWOT Analysis
        13.3.2    Atricure Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials 
           13.3.2.4 SWOT Analysis
        13.3.3    Biosense Webster Inc.
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio 
        13.3.4    Biotronik
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio 
           13.3.4.3 SWOT Analysis
        13.3.5    Cardiofocus Inc.
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
        13.3.6    Hansen Medical Inc. (Auris Health)
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio 
        13.3.7    Johnson & Johnson
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials 
           13.3.7.4 SWOT Analysis
        13.3.8    Siemens Healthineers (Cerner Corporation)
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio 
           13.3.8.3 Financials 
        13.3.9    Stereotaxis Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio 
           13.3.9.3 Financials 
           13.3.9.4 SWOT Analysis

List of Figures

Figure 1: Global: Atrial Fibrillation Market: Major Drivers and Challenges
Figure 2: Global: Atrial Fibrillation Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Atrial Fibrillation Market: Breakup by Disorder Type (in %), 2019
Figure 4: Global: Atrial Fibrillation Market: Breakup by Treatment Type (in %), 2019
Figure 5: Global: Atrial Fibrillation Market: Breakup by End-User (in %), 2019
Figure 6: Global: Atrial Fibrillation Market: Breakup by Region (in %), 2019
Figure 7: Global: Atrial Fibrillation Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 8: Global: Atrial Fibrillation (Paroxysmal Atrial Fibrillation) Market: Sales Value (in Million US$), 2014 & 2019
Figure 9: Global: Atrial Fibrillation (Paroxysmal Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 10: Global: Atrial Fibrillation (Persistent Atrial Fibrillation) Market: Sales Value (in Million US$), 2014 & 2019
Figure 11: Global: Atrial Fibrillation (Persistent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 12: Global: Atrial Fibrillation (Permanent Atrial Fibrillation) Market: Sales Value (in Million US$), 2014 & 2019
Figure 13: Global: Atrial Fibrillation (Permanent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 14: Global: Atrial Fibrillation (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 15: Global: Atrial Fibrillation (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 16: Global: Atrial Fibrillation (Medical Procedures) Market: Sales Value (in Million US$), 2014 & 2019
Figure 17: Global: Atrial Fibrillation Market (Medical Procedures): Breakup by Type (in %), 2019
Figure 18: Global: Atrial Fibrillation Market (Surgical Procedures): Breakup by Type (in %), 2019
Figure 19: Global: Atrial Fibrillation (Medical Procedures) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 20: Global: Atrial Fibrillation (Medication) Market: Sales Value (in Million US$), 2014 & 2019
Figure 21: Global: Atrial Fibrillation Market (Medication): Breakup by Drug Class (in %), 2019
Figure 22: Global: Atrial Fibrillation (Medication) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 23: Global: Atrial Fibrillation (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
Figure 24: Global: Atrial Fibrillation (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 25: Global: Atrial Fibrillation (Cardiac Labs) Market: Sales Value (in Million US$), 2014 & 2019
Figure 26: Global: Atrial Fibrillation (Cardiac Labs) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 27: Global: Atrial Fibrillation (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2014 & 2019
Figure 28: Global: Atrial Fibrillation (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 29: Global: Atrial Fibrillation (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 30: Global: Atrial Fibrillation (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 31: North America: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 32: North America: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 33: United States: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 34: United States: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 35: Canada: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 36: Canada: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 37: Asia Pacific: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 38: Asia Pacific: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 39: China: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 40: China: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 41: Japan: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 42: Japan: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 43: India: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 44: India: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 45: South Korea: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 46: South Korea: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 47: Australia: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 48: Australia: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 49: Indonesia: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 50: Indonesia: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 51: Others: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 52: Others: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 53: Europe: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 54: Europe: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 55: Germany: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 56: Germany: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 57: France: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 58: France: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 59: United Kingdom: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 60: United Kingdom: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 61: Italy: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 62: Italy: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 63: Spain: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 64: Spain: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 65: Russia: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 66: Russia: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 67: Others: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 68: Others: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 69: Latin America: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 70: Latin America: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 71: Brazil: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 72: Brazil: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 73: Mexico: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 74: Mexico: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 75: Others: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 76: Others: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 77: Middle East and Africa: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
Figure 78: Middle East and Africa: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 79: Global: Atrial Fibrillation Industry: SWOT Analysis
Figure 80: Global: Atrial Fibrillation Industry: Value Chain Analysis
Figure 81: Global: Atrial Fibrillation Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Atrial Fibrillation Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Atrial Fibrillation Market Forecast: Breakup by Devices (in Million US$), 2020-2025
Table 3: Global: Atrial Fibrillation Market Forecast: Breakup by Drug Class (in Million US$), 2020-2025
Table 4: Global: Atrial Fibrillation Market Forecast: Breakup by Application (in Million US$), 2020-2025
Table 5: Global: Atrial Fibrillation Market Forecast: Breakup by End-User (in Million US$), 2020-2025
Table 6: Global: Atrial Fibrillation Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 7: Global: Atrial Fibrillation Market Structure
Table 8: Global: Atrial Fibrillation Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links